Literature DB >> 1362387

Alcohol dehydrogenase genes: restriction fragment length polymorphisms for ADH4 (pi-ADH) and ADH5 (chi-ADH) and construction of haplotypes among different ADH classes.

K Edman1, W Maret.   

Abstract

Of the five human alcohol dehydrogenase (ADH) genes located in the region q21-25 of chromosome 4, genetic markers have been reported previously only for class I enzymes, ADH1-3. Here, new restriction fragment length polymorphisms (RFLPs) are described for the genes of two other classes, ADH4 (pi) and ADH5 (chi or formaldehyde dehydrogenase, FDH). The frequencies and modes of inheritance of these RFLPs were determined with DNA both from unrelated individuals and from families. A polymorphic PstI site is assigned to the fourth intron of the ADH4 gene. Pairwise linkage disequilibrium calculations for these new RFLPs and already known RFLPs at the ADH2 and ADH3 loci establish strong linkage disequilibria between polymorphic MspI and BstXI sites in the ADH5 gene as well as between XbaI and MspI sites in the ADH3 gene. Furthermore, linkage disequilibria were detected between RFLPs of the ADH2 and ADH3 genes as well as between those of the ADH4 and ADH5 genes. The latter disequilibrium implies a hitherto unknown physical proximity of two genes belonging to different ADH classes. The RFLPs were used to construct chromosomal haplotypes that include three ADH classes. Of the 16 possible haplotypes for four RFLP markers used here, 10 were experimentally detected. The potential application of the ADH RFLPs and haplotypes in linkage or association studies of inherited diseases such as familial "alcoholism" is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362387     DOI: 10.1007/bf00220466

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  35 in total

1.  An MspI RFLP in the human ADH5 gene.

Authors:  K Edman; W Maret
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

2.  PvuII RFLP detected by a human beta ADH cDNA probe.

Authors:  A Parsian; A K Burgess; M A Khan; E J Devor
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

3.  Evidence for increased recombination near the human insulin gene: implication for disease association studies.

Authors:  A Chakravarti; S C Elbein; M A Permutt
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

Review 4.  DNA polymorphism and human disease.

Authors:  J F Gusella
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

5.  Molecular genetic studies on alcohol and aldehyde dehydrogenase: individual variation, gene mapping and analysis of regulation.

Authors:  M Smith
Journal:  Biochem Soc Trans       Date:  1988-06       Impact factor: 5.407

6.  The relative efficiency of restriction enzymes: an update.

Authors:  E J Devor
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

7.  Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase.

Authors:  M Koivusalo; M Baumann; L Uotila
Journal:  FEBS Lett       Date:  1989-10-23       Impact factor: 4.124

8.  A human alcohol dehydrogenase gene (ADH6) encoding an additional class of isozyme.

Authors:  M Yasunami; C S Chen; A Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

9.  Cloning and characterization of the human ADH4 gene.

Authors:  H von Bahr-Lindström; H Jörnvall; J O Höög
Journal:  Gene       Date:  1991-07-22       Impact factor: 3.688

10.  Neurogenetic adaptive mechanisms in alcoholism.

Authors:  C R Cloninger
Journal:  Science       Date:  1987-04-24       Impact factor: 47.728

View more
  8 in total

1.  Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism.

Authors:  C C Chen; R B Lu; Y C Chen; M F Wang; Y C Chang; T K Li; S J Yin
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Linkage disequilibrium at the ADH2 and ADH3 loci and risk of alcoholism.

Authors:  M Osier; A J Pakstis; J R Kidd; J F Lee; S J Yin; H C Ko; H J Edenberg; R B Lu; K K Kidd
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

Review 3.  Good genes, oxidative stress and condition-dependent sexual signals.

Authors:  T von Schantz; S Bensch; M Grahn; D Hasselquist; H Wittzell
Journal:  Proc Biol Sci       Date:  1999-01-07       Impact factor: 5.349

4.  A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity.

Authors:  Michael V Osier; Andrew J Pakstis; Himla Soodyall; David Comas; David Goldman; Adekunle Odunsi; Friday Okonofua; Josef Parnas; Leslie O Schulz; Jaume Bertranpetit; Batsheva Bonne-Tamir; Ru-Band Lu; Judith R Kidd; Kenneth K Kidd
Journal:  Am J Hum Genet       Date:  2002-06-05       Impact factor: 11.025

5.  Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence.

Authors:  Xingguang Luo; Henry R Kranzler; Lingjun Zuo; Shuang Wang; Nicholas J Schork; Joel Gelernter
Journal:  Am J Hum Genet       Date:  2006-04-11       Impact factor: 11.025

6.  Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer.

Authors:  Kala Visvanathan; Rosa M Crum; Paul T Strickland; Xiaojun You; Ingo Ruczinski; Sonja I Berndt; Anthony J Alberg; Sandra C Hoffman; George W Comstock; Douglas A Bell; Kathy J Helzlsouer
Journal:  Alcohol Clin Exp Res       Date:  2007-03       Impact factor: 3.455

Review 7.  Human variability and susceptibility to trichloroethylene.

Authors:  G M Pastino; W Y Yap; M Carroquino
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

8.  Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.

Authors:  Qifan Zhang; Shibo Sun; Chen Zhu; Yujian Zheng; Qing Cai; Xiaolu Liang; Haorong Xie; Jie Zhou
Journal:  Mol Med Rep       Date:  2019-02-04       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.